Pressure Biosciences Inc (PBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,699 | -10,716 | -2,707 | -7,415 | -4,613 |
| Depreciation Amortization | 1,612 | 4,137 | 4,354 | 3,472 | 1,683 |
| Accounts receivable | -268 | 75 | -196 | 159 | -124 |
| Accounts payable and accrued liabilities | 70 | 182 | -534 | -94 | -67 |
| Other Working Capital | 613 | 2,034 | -451 | 85 | -269 |
| Other Operating Activity | 1,977 | 383 | -4,272 | -25 | 179 |
| Operating Cash Flow | $-5,696 | $-3,905 | $-3,806 | $-3,820 | $-3,211 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -22 | -7 | -9 | -7 |
| Purchase Sale Intangibles | N/A | -150 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -150 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $-172 | $-7 | $-9 | $-7 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,832 | 4,976 | 2,156 | 1,257 | 302 |
| Debt Issued | 5,886 | 1,756 | 2,222 | 5,565 | 1,127 |
| Debt Repayment | -3,626 | -926 | -127 | -2,666 | -310 |
| Common Stock Issued | N/A | 140 | 531 | 0 | 1,012 |
| Other Financing Activity | 625 | -1,927 | -948 | -684 | 1,529 |
| Financing Cash Flow | $5,718 | $4,019 | $3,835 | $3,472 | $3,660 |
| Beginning Cash Position | 81 | 138 | 117 | 474 | 31 |
| End Cash Position | 103 | 81 | 138 | 117 | 474 |
| Net Cash Flow | $22 | $-57 | $22 | $-357 | $443 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,696 | -3,905 | -3,806 | -3,820 | -3,211 |
| Capital Expenditure | N/A | -22 | -7 | -9 | -7 |
| Free Cash Flow | -5,696 | -3,926 | -3,813 | -3,829 | -3,218 |